Corrigendum to "Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells" [Biologicals 43 (2) (March 2015) 146-149]
Biologicals. 2017 Jan:45:106.
doi: 10.1016/j.biologicals.2016.11.003.
Epub 2016 Nov 19.
1 Division of Medical Devices, National Institute of Health Sciences, 1-18-1 Kami-yoga, Setagaya, Tokyo, 158-8501, Japan.
2 Division of Cellular & Gene Therapy Products, National Institute of Health Sciences, 1-18-1 Kami-yoga, Setagaya, Tokyo, 158-8501, Japan; Research on Disease Bioresources, Platform of Therapeutics for Rare Disease and Health Policy, National Institute of Biomedical Innovation, Kobe International Business Center Rm#602, 5-5-2 Minatojima-Minami-Machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
3 Division of Cellular & Gene Therapy Products, National Institute of Health Sciences, 1-18-1 Kami-yoga, Setagaya, Tokyo, 158-8501, Japan; Foundation for Biomedical Research and Innovation, Hyogo, Japan.
4 Research on Disease Bioresources, Platform of Therapeutics for Rare Disease and Health Policy, National Institute of Biomedical Innovation, Kobe International Business Center Rm#602, 5-5-2 Minatojima-Minami-Machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
5 Division of Cellular & Gene Therapy Products, National Institute of Health Sciences, 1-18-1 Kami-yoga, Setagaya, Tokyo, 158-8501, Japan; Foundation for Biomedical Research and Innovation, Hyogo, Japan; Department of Quality Assurance Science for Pharmaceuticals, Graduate School of Pharmaceutical Sciences, Nagoya City University, Aichi, Japan; Department of Cellular & Gene Therapy Products, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan; Department of Translational Pharmaceutical Sciences, Graduated School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: [email protected].